Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Lecture: Current use of systemic therapies in localised disease

Dr Rainy Umbas - University of Indonesia, Jakarta, Indonesia

Lecture: Current use of systemic therapies in localised disease ( Dr Rainy Umbas - University of Indonesia, Jakarta, Indonesia )

Lecture: Current standard of care in advanced disease

Dr Wayne YH Chang - National Yang-Ming University Taipei, Taiwan

Lecture: Current standard of care in advanced disease ( Dr Wayne YH Chang - National Yang-Ming University Taipei, Taiwan )

Lecture: Exploring the androgen signalling pathway in CRPC

Dr Paul de Souza - University of Western Sydney, New South Wales, Australia

Lecture: Exploring the androgen signalling pathway in CRPC ( Dr Paul de Souza - University of Western Sydney, New South Wales, Australia )

Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC

Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany;

Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC ( Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany; )

Debate: Will chemotherapy continue to be standard treatment for symptomatic...

Dr Paul de Souza - University of Western Sydney, New South Wales, Australia

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (for) ( Dr Paul de Souza - University of Western Sydney, New South Wales, Australia )

Lecture: Clinical Perspectives: How far are we from personalising treatment for...

Dr Paul de Souza - University of Western Sydney, New South Wales, Australia

Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients? ( Dr Paul de Souza - University of Western Sydney, New South Wales, Australia )

Debate: Will chemotherapy continue to be standard treatment for symptomatic...

Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (against) ( Dr Kurt Miller - Benjamin Franklin Medical Center, Berlin, Germany )

Lecture: Future strategies and targets for prostate cancer

Dr Kurt Miller - Benjamin Franklin Medical Center Berlin, Germany

Lecture: Future strategies and targets for prostate cancer ( Dr Kurt Miller - Benjamin Franklin Medical Center Berlin, Germany )

Idelalisib shows promising results in patients with double refractory indolent...

Dr Andrew Davies - Southampton General Hospital, Southampton, UK;

$Idelalisib shows promising results in patients with double refractory indolent B-cell non-Hodgkin's lymphoma ( Dr Andrew Davies - Southampton General Hospital, Southampton, UK; )$

Rituximab versus idelalisib in refractory CLL

Prof John Gribben - Queen Mary University London, London, UK; Prof Peter...

$Rituximab versus idelalisib in refractory CLL ( Prof John Gribben - Queen Mary University London, London, UK; Prof Peter Hillmen - St James’ University Hospital, Leeds, UK )$

New agents extend progression-free survival in double refractory myeloma

Dr Jonathan Kaufman - Winship Cancer Institute of Emory University, Atlanta...

$New agents extend progression-free survival in double refractory myeloma ( Dr Jonathan Kaufman - Winship Cancer Institute of Emory University, Atlanta, USA )$

Aspirin analogues developed for anti-cancer effects on leukaemia

Dr Chris Pepper - Cardiff University School of Medicine, Cardiff, UK

Aspirin analogues developed for anti-cancer effects on leukaemia ( Dr Chris Pepper - Cardiff University School of Medicine, Cardiff, UK )

More from ecancer